SANGUI BIOTECH INTERNATIONAL INC: 10-Q filed 2017-02-22
What SANGUI BIOTECH INTERNATIONAL INC reported in its quarterly report filed 2017-02-22 (fiscal Q2 2017): 23 published measures, 64 facts as tagged in accession 0001551163-17-000020.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-02-22
- Fiscal period
- fiscal Q2 2017
- Accession
- 0001551163-17-000020 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SANGUI BIOTECH INTERNATIONAL INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 165,838 | USD | |
| At 2016-06-30 | 110,419 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | -223,324 | USD | |
| At 2016-06-30 | -247,566 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 180,122 | USD | |
| At 2016-06-30 | 70,074 | USD | |
| At 2015-12-31 | 88,273 | USD | |
| At 2015-06-30 | 17,672 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-12-31 | -218,615 | USD | 184 |
| 2015-07-01 to 2015-12-31 | -258,839 | USD | 184 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-12-31 | -183,379 | USD | 184 |
| 2015-07-01 to 2015-12-31 | -1,925 | USD | 184 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-01 to 2016-12-31 | 25,797 | USD | 92 |
| 2016-07-01 to 2016-12-31 | 35,508 | USD | 184 |
| 2015-10-01 to 2015-12-31 | 15,385 | USD | 92 |
| 2015-07-01 to 2015-12-31 | 26,856 | USD | 184 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-12-31 | 233,950 | USD | 184 |
| 2015-07-01 to 2015-12-31 | 232,698 | USD | 184 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-12-31 | 6,977 | USD | 184 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | -36,878,435 | USD | |
| At 2016-06-30 | -36,669,318 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 173 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-01 to 2016-12-31 | -148,722 | USD | 92 |
| 2016-07-01 to 2016-12-31 | -218,615 | USD | 184 |
| 2015-10-01 to 2015-12-31 | -141,890 | USD | 92 |
| 2015-07-01 to 2015-12-31 | -249,590 | USD | 184 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 152,722 | USD | |
| At 2016-06-30 | 110,419 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-01 to 2016-12-31 | -1,053 | USD | 92 |
| 2016-07-01 to 2016-12-31 | -2,835 | USD | 184 |
| 2015-10-01 to 2015-12-31 | -14,926 | USD | 92 |
| 2015-07-01 to 2015-12-31 | -16,327 | USD | 184 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 389,162 | USD | |
| At 2016-06-30 | 357,985 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-01 to 2016-12-31 | 174,143 | USD | 92 |
| 2016-07-01 to 2016-12-31 | 263,465 | USD | 184 |
| 2015-10-01 to 2015-12-31 | 157,131 | USD | 92 |
| 2015-07-01 to 2015-12-31 | 276,217 | USD | 184 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-01 to 2016-12-31 | 25,421 | USD | 92 |
| 2016-07-01 to 2016-12-31 | 34,850 | USD | 184 |
| 2015-10-01 to 2015-12-31 | 15,241 | USD | 92 |
| 2015-07-01 to 2015-12-31 | 26,627 | USD | 184 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-01 to 2016-12-31 | 3,908 | USD | 92 |
| 2016-07-01 to 2016-12-31 | 8,328 | USD | 184 |
| 2015-10-01 to 2015-12-31 | 1,455 | USD | 92 |
| 2015-07-01 to 2015-12-31 | 35,507 | USD | 184 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 4,513,328 | USD | |
| At 2016-06-30 | 4,513,328 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 124,912 | USD | |
| At 2016-06-30 | 122,789 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-01 to 2016-12-31 | -149,775 | USD | 92 |
| 2016-07-01 to 2016-12-31 | -221,450 | USD | 184 |
| 2015-10-01 to 2015-12-31 | -149,738 | USD | 92 |
| 2015-07-01 to 2015-12-31 | -258,839 | USD | 184 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-01 to 2016-12-31 | -149,775 | USD | 92 |
| 2016-07-01 to 2016-12-31 | -221,450 | USD | 184 |
| 2015-10-01 to 2015-12-31 | -149,738 | USD | 92 |
| 2015-07-01 to 2015-12-31 | -258,839 | USD | 184 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-01 to 2016-12-31 | 40,755 | USD | 92 |
| 2016-07-01 to 2016-12-31 | 75,947 | USD | 184 |
| 2015-10-01 to 2015-12-31 | 42,048 | USD | 92 |
| 2015-07-01 to 2015-12-31 | 84,565 | USD | 184 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-12-31 | -170 | USD | 184 |
| 2015-07-01 to 2015-12-31 | -16,860 | USD | 184 |
Inspect the source
- Entity
- SANGUI BIOTECH INTERNATIONAL INC / CIK 0001104280
- Captured
- SEC response SHA-256
80929a3d07bdd3be99cfb5858d464edb9844d0e622d958ee5dce9515baeeed6f
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001104280.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))